4/A//SEC Filing
MERZOUKI ABDERRAZZAK 4/A
Accession 0001128732-19-000029
CIK 0001402328other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 7:10 PM ET
Size
4.7 KB
Accession
0001128732-19-000029
Insider Transaction Report
Form 4/AAmended
MERZOUKI ABDERRAZZAK
DirectorChief Operating Officer
Transactions
- Award
Common Stock
2017-07-20$0.00/sh+14,000,000$14,000→ 52,000,000 total
Documents
Issuer
Sunshine Biopharma, Inc
CIK 0001402328
Entity typeother
Related Parties
1- filerCIK 0001636418
Filing Metadata
- Form type
- 4/A
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 7:10 PM ET
- Size
- 4.7 KB